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Abstract 22 
2 
 
Silver nanoparticles (AgNP) have strong broad-spectrum antimicrobial activity and gained 23 
increased attention for the development of AgNP based products, including medical and 24 
food applications. Initially, the efficacy of AgNP and silver nitrate (AgNO3) was evaluated 25 
for inactivating norovirus surrogates, the feline calicivirus (FCV) and the murine norovirus 26 
(MNV). These norovirus surrogates were exposed to AgNO3 and AgNP solutions for 24 h 27 
at 25°C and then analyzed by cell-culture assays. Both AgNP and silver ions significantly 28 
decreased FCV and MNV infectivity in a dose-dependent manner between concentrations 29 
of 2.1 and 21 mg/L. Furthermore, poly (3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) 30 
films were prepared by depositing a coating of thermally post-processed electrospun 31 
PHBV18 /AgNP fiber mats over compression moulded PHBV3 films. After 24 h exposure 32 
at 37°C and 100% RH, no infectious FCV were recovered when in contact with the AgNP 33 
films while MNV titers decreased by 0.86 log. The morphology of the PHBV18 and 34 
PHBV18/AgNP fibers studied by SEM showed smooth and continuous fibers in both cases 35 
and the EDAX analysis confirmed the homogeneously distribution of AgNP into the 36 
coating and onto the PHBV3/PHBV18 layer. This study showed, for the first time, the 37 
suitability of the PHBV18/AgNP electrospun coating for antiviral surfaces.  38 
 39 
Keywords: Noroviruses, Silver nanoparticles, Active packaging, Polyhydroxyalkanoates, 40 
Electrospinning. 41 
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1. Introduction 43 
Human norovirus (family Caliciviridae) are reported as the leading causes of viral 44 
gastroenteritis in industrialized countries, and worldwide constituting a high public health 45 
concern. Norovirus gastroenteritis is self-limiting but extremely infectious with a low 46 
infectious dose (10-100 particles). This non-enveloped, single-stranded, positive-sense 47 
RNA virus is responsible for over 90% cases of non-bacterial and approximately half of all 48 
cases of gastroenteritis. Recently, the World Health Organization has estimated the global 49 
burden of foodborne diseases, reporting that infectious agents that cause diarrhoeal diseases 50 
accounted for the vast majority (550 million cases per year), in particular human norovirus 51 
(120 million cases per year) (WHO, 2015). 52 
Moreover human norovirus is responsible for many outbreaks, especially in closed 53 
environments e.g. health-care facilities and cruise ships, whereas the contribution of 54 
contaminated surfaces in the spread of infection has a key role (Lopman et al., 2012). To 55 
effectively prevent norovirus outbreaks, the scientific community has been working to 56 
develop strategies for treating and preventing norovirus infection. The use of antimicrobial 57 
surfaces in food, clinical and community environments may help to reduce the spread of 58 
norovirus infection. Among them, the use of silver has emerged as a very efficient 59 
technology to prevent microbial proliferation on medical and food-contact surfaces 60 
(Kuorwel et al., 2015) and, more concretely, silver nanoparticles (AgNP) have received 61 
considerable attention due to their attractive physico-chemical and antimicrobial properties 62 
(Rai, Yadav, & Gade, 2009; Moritz & Geszke-Moritz, 2013) such as the high surface-to-63 
volume ratio, nanosize diameter and enhanced surface reactivity, making them able to 64 
inactivate microorganisms more effectively than their micro- or macro- scale counterparts. 65 
For instance, Castro-Mayorga and collaborators (Castro-Mayorga, Fabra, & Lagaron, 66 
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2016a) have demonstrated that poly (3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV)-67 
AgNP packaging materials exhibited a strong and prolonged (even after seven months) 68 
antibacterial activity against Listeria monocytogenes and Salmonella enterica at very low 69 
AgNP loadings (0.4 g/kg). On the other hand, Martínez-Abad and collaborators (Martínez-70 
Abad  et al., 2013) developed active renewable food packaging materials based on 71 
polylactic acid (PLA) and silver ions (from 0.1 to 10 g/kg) to control feline calicivirus 72 
(FCV) in vegetables. These packaging materials showed a remarkable potential for food-73 
contact applications as well as active packaging to maintain or extend food quality and 74 
safety. However, the maximal antimicrobial potential can hardly be achieved in most cases 75 
because silver has low solubility or compatibility with the polymers matrices, leading to the 76 
agglomeration and blackening of the films, or simply because the amount of silver available 77 
in the film surface is insufficient to exert antimicrobial effect.   78 
As an alternative, metal nanoparticles can be incorporated into sub-micro or nano fibers by 79 
means of electrospinning technique in order to generate masterbatches which are 80 
subsequently melt, mixed with polymers pellets, or even better, used as active coating over 81 
polymer surfaces (Amna et al., 2014). The electrospun fibres lead the development of novel 82 
materials with useful features for antibacterial applications such as fibrous membranes for 83 
water filtration (Botes & Cloete, 2010), wound dressings, implant materials or tissue 84 
engineering (Navalakhe & Nandedkare, 2007). Concretely, in the area of active food 85 
packaging, the electrospinning technique successfully avoids the agglomerations of zinc 86 
oxide nanoparticles and greatly increases their antimicrobial activity (Castro-Mayorga et al. 87 
2016c).  88 
Since human noroviruses cannot routinely be propagated by using cell-culture systems, 89 
cultivable surrogates such as FCV and murine norovirus (MNV) are commonly used as 90 
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experimental models to study human norovirus infectivity and the efficacy of inactivation 91 
technologies (D'Souza, 2014). Pioneering studies demonstrated the potential of silver ions 92 
and silver nanoparticles for enteric virus inactivation (Abad et al., 1994; Silvestry-93 
Rodriguez at al., 2007; Galdiero et al., 2011; Khandelwal at al., 2014; De Gusseme et al., 94 
2010; Bekele et al., 2016). However, it is known that silver ions are easily inactivated by 95 
many different physical or chemical factors (Ilg & Kreyenschmidt, 2011; Castro-Mayorga 96 
et al, 2016b). For instance, thermal treatments or exposure to light or UV can prompt the 97 
formation of sulphides or other silver complexes without antimicrobial properties and 98 
usually producing a strong brownish or blackish coloration of the materials (Kasuga et al., 99 
2012). Accordingly, the use of stabilized AgNP could not only improve the thermal 100 
stability, the visual appearance and optical properties of the active films but also enhance 101 
their antimicrobial performance. However, there is lack of information about the influence 102 
of storage time on their antiviral activity and its efficacy when incorporated into 103 
composites. Thus, silver nitrate and silver nanoparticles at different concentrations and with 104 
different aging time were investigated for their effect on norovirus surrogates. In the first 105 
part of this work, norovirus surrogates were exposed to different concentrations of silver 106 
nitrate and the virucidal activity was assessed using cell culture. In the second part, 107 
PHBV18/AgNP fiber mats were fabricated by electrospinning and used to coat PHBV3 108 
films in order to develop virucidal biopolymers that may be suitable as active material, 109 
particularly in food and medical contact surfaces.  110 
 111 
2. Material and methods 112 
2.1. Silver nitrate and silver nanoparticles 113 
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Stabilized AgNP were synthesized by chemical reduction into unpurified poly (3-114 
hydroxybutyrate-co-18 mol%- 3-hydroxyvalerate) (PHBV18) suspension according to a 115 
previously reported method (Castro-Mayorga et al., 2014). To this end, 500 mg/kg of 116 
PHBV18 was suspended in ultrapure Milli-Q® water (Millipore Corporation Co., USA) 117 
and then sodium borohydride was added to get 75.7 mg/L concentration. Thereafter, 10 mL 118 
of an aqueous AgNO3 solution at 169.9 mg/L was added dropwise to generate in situ 119 
stabilized silver nanoparticles. The obtained PHBV18/AgNP suspension was centrifuged at 120 
17387×g for 15 min and the precipitate was dried at 40°C under vacuum for 24 h. The dried 121 
material was used as stock to evaluate the antiviral activity at three different concentrations 122 
(21, 10.5 and 2.1 mg/L). Analogous AgNO3 solution (without PHBV18 and without 123 
sodium borohydride) was prepared to compare the antiviral activity of silver ions to AgNP.  124 
 125 
2.2. Viral strains, cell lines and infections 126 
Murine norovirus (MNV-1 strain) was propagated and assayed in RAW 264.7 cells. Feline 127 
calicivirus (F9 strain, ATCC VR-782) was cultured in CRFK cells (ATCC CCL-94). Semi-128 
purified viruses were obtained following three cycles of freeze-thawing infected cells and 129 
centrifugation at 660×g for 30 min. The supernatant was stored at -80°C until use. 130 
Infectious viruses were enumerated by determining the 50% tissue culture infectious dose 131 
(TCID50) with eight wells per dilution and 20 μL of inoculum per well using the Spearman-132 
Karber method (Abad et al., 1994). 133 
 134 
2.3. Determination of antiviral activity 135 
Each silver solution was mixed with an equal volume of each virus suspension and further 136 
incubated at 25°C in a water-bath shaker at 150 rpm for 16 h (overnight). Then, infectious 137 
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viruses were enumerated by cell culture assays as described above. Positive controls were 138 
virus suspensions added with water. Antiviral activity of silver was estimated by comparing 139 
the number of infectious viruses on suspensions without silver and on the silver-treated 140 
virus suspensions. Each treatment was performed in triplicate. The value of antiviral 141 
activity (Reduction, R) was calculated by determining log10 (N0/Nt), where N0 is the 142 
number of infections viruses on the suspension without silver and Nt is the number of 143 
infections viruses on the suspension added with silver.  144 
 145 
2.4. Preparation of AgNP based films 146 
A coated structure was fabricated by coating the poly(3-hydroxybutyrate-co-3 mol%- 3-147 
hydroxyvalerate) (PHBV3) films with PHBV18/AgNP fibers mat produced by means of the 148 
electrospinning technique. PHBV3 films used as matrix were compression molded using 149 
hot plates hydraulic press (Carver 4122, USA) at 180°C, 1.8 MPa during 5 min. The so-150 
obtained films had a thickness of 246±22 µm as measured with a digital micrometer 151 
(Mitutoyo, Spain, ± 0.001 mm) by averaging four measurements on each sample.  152 
To prepare the active coating, AgNP were firstly synthesized by chemical reduction into 153 
polymer suspensions on the bases of a previously reported method (Castro-Mayorga et al., 154 
2014). Then, PHBV18/AgNP masterbatch was dispersed in 2,2,2-Trifuoroethanol (TFE, ≥ 155 
99 %, Sigma Aldrich) having a total solids content of 60 g/kg The biopolymer solution was 156 
transferred to a 5 mL glass syringes, connected through polytetrafluoroethylene (PTFE) 157 
tubes to a stainless steel needle (0.9 mm of inner diameter) and processed using a 158 
Fluidnatek® LE-10 electrospinning equipment, trademark of the engineering division of 159 
Bioinicia S.L. (Valencia, Spain). Processed samples were collected on a stainless-steel plate 160 
connected to the cathode of the power supply and oriented perpendicular to the syringe. 161 
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The distance between the needle and the plate was 12 cm and the voltage was maintained in 162 
the range 10-12 kV. All experiments were carried out at room temperature under a steady 163 
flow-rate of 7 mL/h. After electrospinning, the fiber mats were dried at 40°C under vacuum 164 
for 24 h to completely remove the solvent.  165 
Finally, the coated structure was assembled placing 250-300 g/kg of fiber mat of about 100 166 
µm of thickness onto PHBV3 films. The resulting coated system was thermally post-167 
processed in a hot press (Carver 4122, USA) at 150C during 2 min (without pressing) to 168 
form a continuous film by fiber coalescence.  169 
Neat PHBV3/PHBV18 films without silver were used as control for comparative purposes. 170 
 171 
2.5. Scanning Electron Microscopy (SEM)  172 
The morphology of the PHBV18/AgNP electrospun fibers and bilayer films was analyzed 173 
using SEM. The SEM was conducted on a Hitachi microscope (Hitachi S–4800) at an 174 
accelerating voltage of 5 kV and a working distance of 8-10 mm before the examination, 175 
the films were cryo-fractured using liquid N2 and sputtered with Au/Pd under vacuum. The 176 
microanalysis and elemental mapping were conducted by Energy Dispersive Analysis of X-177 
rays (EDAX) from SEM images of carbon coated samples. Fibers thicknesses were 178 
measured by means of the of the Adobe Photoshop CS4 software from 300 fibers at random 179 
from SEM images.   180 
 181 
2.6. Determination of virucidal activity of silver based films 182 
To test the virucidal activity of silver based films, a modification of the ISO 22196:2011 183 
(Measurement of antibacterial activity on plastics and other non-porous surfaces) was used. 184 
Briefly, a suspension of viruses diluted in PBS buffer (4-6 log TCID50/mL) was placed onto 185 
9 
 
the test films of 3×3 cm and covered by an inert piece of Low-Density Polyethylene 186 
(LDPE) of 2.5×2.5 cm and 10 μm thickness. Samples were incubated at 37 or 25°C 187 
overnight at 100% relative humidity (RH). Thereafter, the top film was lifted, and the virus 188 
droplet-exposed sides were recovered and 10-fold diluted with PBS. Lastly, the 189 
corresponding cell culture assays were performed to determine whether the silver films 190 
were effective in inactivating the tested viruses. A control film (without silver) was used as 191 
the negative control material. 192 
Virucidal activity was calculated by comparing the number of infectious viruses on control 193 
films (without silver) and on the silver films. Each experimental condition was performed 194 
in triplicate. 195 
 196 
2.7. Determination of silver content  197 
The quantification of total silver content in the developed films was carried out by 198 
inductively coupled plasma- optical emission spectroscopy (ICP-OES, Perkin-Elmer, USA) 199 
using  silver standard solution (traceable to SRM from NIST, AgNO₃ in HNO₃ 2-3 % 1000 200 
mg/L Ag Certipur®, Merck, Germany) for calibration. To this end, 100 mg of sample were 201 
subjected to acid digestion with 2 mL of HNO3 (69% for trace metal analysis, Panreac, 202 
Spain) at 80°C for 16 h. The resultant digestant was diluted to a final volume of 5 mL and 203 
analyzed.  All measurements were done, at least, in triplicate. 204 
 205 
2.8. Statistical analysis 206 
The significance of differences among the mean numbers of viruses determined after the 207 
control and AgNP films to assess the antiviral effect was determined by Student's t test with 208 
a significance level of p<0.05. The post-hoc Tukey's method (p<0.05) was used for 209 
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pairwise comparison and to determine differences among silver nitrate and silver 210 
nanoparticles treatments on viruses (XLSTAT, Addinsoft SARL). 211 
 212 
3. Results and discussion 213 
3.1. The effect of silver nitrate and silver nanoparticles on MNV and FCV  214 
As shown in Fig.1 and 2, in all tested aging times, the exposition of norovirus surrogates, 215 
MNV and FCV, to silver ions or silver nanoparticles, produced a clear reduction in the 216 
virus titers. The results indicated that the antiviral activity of silver, in any of its forms, is 217 
dose-dependent, where increasing concentrations of silver showed increased reduction in 218 
viral titers.  219 
In the case of MNV, the silver nitrate suspension produced a higher reduction of MNV 220 
infectivity during the first 75 days of aging. However, the antiviral activity was 221 
significantly reduced after 150 days of storage probably due to the physical and chemical 222 
instability of silver ions (i.e. reduction and aggregation) as it has been previously reported 223 
(Castro-Mayorga et al., 2014). Silver ions can be reduced to elemental silver or silver 224 
nanoparticles by weak reducing treatments, such as many solvents, UV-light, thermal 225 
treatment, ligands, etc. Since water was used as a solvent, external agents such as UV-light 226 
could compromise the stability of silver ions and the formation of elemental silver and 227 
silver nanoparticles in uncontrolled way forming particles with different forms and size 228 
which are not stabilized and can easily coalesce. In fact, one of the main problems which 229 
could compromise the final properties of an antimicrobial/antiviral packaging material is 230 
the stability of silver ions and the chemical environment where the material has to exert its 231 
effect and even the conditions to which the material will be exposed (Martínez-Abad, 232 
Lagarón, & Ocio, 2014).  233 
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In contrast, the antiviral activity of silver nanoparticles at concentrations higher than 2.1 234 
ppm increased or remained constant during all the time evaluated (150 days) (Fig.1). This 235 
effect can be ascribed to the nanosize diameter of AgNP (7±3 nm previously reported by 236 
Castro-Mayorga et al. (2014)) and the enhanced surface reactivity, making them able to 237 
affect more effectively the capsid of the viruses. Indeed, a synergic effect between silver 238 
ions release from the AgNP and AgNP themselves might enhance and extend the virucidal 239 
activity. The initial increase in the antiviral activity of the AgNP could be attributed to both 240 
the action of residual silver ions and the excess of reducing agent which could produce 241 
some more nanoparticles in the first days of the storage, increasing the virucidal efficacy. It 242 
is worth mentioning that the in situ synthesis of AgNP implied their stabilization in a 243 
biopolymer matrix (PHBV18) which could also enhanced their virucidal activity preventing 244 
the aggregation of AgNP, as had been demonstrated by Castro-Mayorga et al. (2014) for 245 
enhancing the antimicrobial activity. As a result, the AgNP suspensions exhibited a high 246 
and prolonged (even after 150 days) virucidal activity against MNV.   247 
On the other hand, the FCV appeared more susceptible to the action of silver nitrate and the 248 
reduction in viral titers was higher than for their counterparts obtained for MNV (Fig.2). 249 
This appreciation leads to infer that the virucide effect of silver might depend to the 250 
differences in capsid structure and capsid composition of the treated virus. Thus, for FCV, 251 
the silver nitrate suspension had a highest reduction of its infectivity. This fact could be a 252 
consequence of a combined effect between the high activity of soluble silver ions and the 253 
higher susceptibility of FCV at Ag0 particles produced by uncontrolled reduction (having 254 
bigger size). Both, silver ions and the Ag0 formed in the suspension could be able to disrupt 255 
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the FCV capsid more easily than in the case of the MNV. AgNP suspensions followed a 256 
slight different pattern in FCV than in its counterparts prepared with MNV (Fig. 2).   257 
To sum up, the results revealed that silver nitrate and AgNP were effective in reducing the 258 
titers of FCV and MNV. The differences found between the virucide activity of the two 259 
different silver forms and the two different viruses evaluated bring to light that might exist 260 
different mechanisms of action depending on the virus structure and composition (Galdiero 261 
et al., 2011). In this respect, the efficacy of a micrometer-sized magnetic hybrid colloid 262 
(MHC) decorated with AgNP has recently been assessed on MNV. Park, et al. (2014) 263 
reported that a suspension of AgNP with a size of 30 nm and a concentration of 400 ppm 264 
(Ag30-MHCs) had the highest antiviral activity, reporting about 6 log10 reduction of MNV 265 
after exposure at 25°C for 6 h while Ag7-MHCs (corresponding to 57.5 mg/L and 7 nm) 266 
did not reduce the MNV infectivity. More recently, Bekele and collaborators (Bekele et al., 267 
2016) have reported the effect of the size (10, 75 and 110 nm) and dose (25, 50 and 100 268 
mg/L) of AgNP on FCV, showing that only the smallest AgNP (10 nm) were effective in 269 
reducing the FCV titers. Therefore, comparing these results with those obtained in the 270 
present study (where the highest antiviral effect was achieved with AgNP of 7±3 nm at 21 271 
mg/L, it could be stated that the virucidal activity of AgNP is strongly dependent on their 272 
stabilization degree, size and concentration.  273 
3.2. Fibers and films morphology   274 
The morphology of the PHBV18 and PHBV18/AgNP fibers obtained from electrospinning 275 
was studied by SEM and representative micrographs are shown in Fig.3a and 3b, 276 
respectively. As it can be observed, smooth and continuous fibers without beads were 277 
attained in both cases. The electrospun fibers presented a diameter of 0.92±0.36 and 278 
1.1±0.40 µm for PHBV18 and PHBV18/AgNP respectively. Interestingly, the addition of 279 
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AgNP did not result in a significant change in fiber diameter as it can be deduced from the 280 
SEM image and size distribution (Fig.3c). However it has been previously reported that the 281 
addition of salts usually increases the charge density in the ejected jets and, thus, stronger 282 
elongation forces are imposed due to the self-repulsion of the excess charges under the 283 
electrical field, resulting in electrospun fibers having straighter shape and smaller diameter 284 
(Jeon et al., 2008; Martínez-Abad et al., 2012). In the present work, the low silver loading, 285 
the appropriate stabilization of AgNP into the polymer matrix and the electrospinning 286 
solution minimize the reduction of residual silver ion and the aggregation of AgNP or any 287 
significant impact on the fiber diameter.  288 
The surface and cross-section of the coated systems prepared with PHBV3 and 289 
PHBV18/AgNP was also analyzed by SEM. The coated system presented a uniform and 290 
smooth surface (Fig.4a) formed by the continuous layer of annealed active fibers whose 291 
thickness was not easily discerned, but it was measured to have a thickness of about 60µm 292 
(Fig.4b). The morphology of the coating layer suggests that a partial melting and 293 
contraction of fibers could take place during the annealing step, favoring the adhesion 294 
between the two layers. Furthermore, the presence of silver was confirmed by EDAX 295 
analysis (Fig.4c) and the AgNP distribution assessed by mapping from the SEM images. 296 
The elemental mapping image of the Fig.4d shows matched spatial distribution of silver, 297 
indicating that the AgNP are homogeneously distributed into the coating and onto the 298 
PHBV3/PHBV18 layer.  299 
Fig.5 shows the overall appearance images of the neat PHBV3 film and the coated systems 300 
containing or not AgNP. The first clear observation is that coated systems prepared without 301 
AgNP showed a darker yellowish coloration as compared to the neat PHBV3. This effect 302 
could be ascribed to the presence of some impurities in the PHBV18 due to the 303 
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fermentation process, which resulted in Maillard reactions during the thermal treatment 304 
(Castro-Mayorga, Fabra & Lagaron, 2016). In contrast, when the AgNP were added to the 305 
coating, the yellowish coloration disappeared and it turned light grey, thus indicating that 306 
both the thermal stability of the polymer matrix and the dispersion of nanoparticles were 307 
enhanced by means of this procedure.     308 
 309 
3.3. Antiviral effects of AgNP films  310 
Taking into account the good performance of AgNP obtained in the first part of this work, 311 
PHBV3/PHBV18/AgNP coated systems were fabricated as described above and their 312 
antiviral activity was evaluated. The AgNP-films were inoculated with norovirus surrogates 313 
adapting the ISO 22196:2011 and incubated at 25°C and 100% RH. Table 1 shows that 314 
FCV and MNV titers decreased by 1.42 and 0.14 log TCID50/mL respectively. However, 315 
the results were not found statistically significant (p>0.05). The effectiveness of AgNP-316 
films was also evaluated at 37°C and 100% RH. After 24 h exposure, no infectious FCV 317 
were recovered when in contact with the AgNP films while MNV titers decreased by 0.86 318 
log TCID50/mL (Table 1). As for other natural compounds AgNP-films exerted the 319 
strongest antiviral effect at 37°C (Sánchez & Aznar, 2015).  320 
In a similar work, an active renewable packaging material with virucide properties was 321 
synthesized by the incorporation of silver ions into PLA films by solvent casting technique. 322 
These films also showed antiviral activity on FCV. When FCV was exposed to PLA-silver 323 
films for 24 h at 25°C, FCV titers decreased by 2 log TCID50/mL when treated with PLA 324 
films at concentrations of 1 g/kg of silver, while in films containing 10 g/kg  of silver, FCV 325 
infectivity was completely eliminated (Martínez-Abad et al., 2013). Likewise, Silvestry-326 
Rodriguez et al. (2007) evaluated the antiviral activity of active packaging, reporting that 327 
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FCV titers were reduced by 5 log when in contact with plastic coupons impregnated with 328 
100 g/kg silver–copper zeolites. In the present study, PHBV3/PHBV18/AgNP films 329 
containing a total silver concentration of 270 ± 10 mg/kg (as it was quantified by ICP-OES) 330 
demonstrated to have a higher antiviral activity against FCV than the above-mentioned 331 
publications. The highest antiviral activity observed for FCV as compared to MNV, could 332 
be due to the release of silver ions from the immobilized AgNP resulting in a final 333 
increased antiviral effect. Even if this assumption is in line with the higher sensitivity of 334 
FCV than MNV to silver ions as reported in the suspension antiviral assay additional 335 
research on the migration of silver ions or silver nanoparticles are required to confirm this 336 
hypothesis.   337 
 338 
Conclusions 339 
The effect of silver nitrate and silver nanoparticles on norovirus surrogates was 340 
investigated. It was found that both chemical forms (i.e. metallic and ionic silver) 341 
significantly decreased the MNV and FCV infectivity in a dose-dependent manner. 342 
Meanwhile, its effect depends on other factors, such as the aging time, the type of virus and 343 
the stabilization degree.       344 
Furthermore, biopolymeric materials consisting of a matrix of poly (3-hydroxybutyrate-co-345 
3-hydroxyvalerate) and AgNP-based coating obtained by means of electrospinning were 346 
also developed. Interestingly, the addition of very low loadings of stabilized AgNP into the 347 
electrospun coating provided a virucidal activity against norovirus surrogates and did not 348 
significantly modify the optical properties of films. The technology here proposed allows 349 
the design of custom made active adapted to the final intended use of packaging and 350 
contact surface industries. 351 
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